Back

Distinct tau filament folds in familial frontotemporal dementia due to the MAPT S305I mutation

Pan, H. S.; Merz, G. E.; Li, A. N.; Le, M. Q.; Jo, H.; Quddus, A.; Yung, A.; Kormos, R.; Melo, A. A.; Ramos, E. M.; Lago, A. L.; Spina, S.; Grinberg, L. T.; Rosen, H. H.; Tse, E.; Gorno-Tempini, M. L.; DeGrado, W. F.; Seeley, W. W.; Southworth, D. R.

2026-02-14 neuroscience
10.64898/2026.02.12.705620 bioRxiv
Show abstract

Frontotemporal lobar degeneration with tau inclusions (FTLD-tau) comprise a class of fatal heterogeneous neurodegenerative diseases. Approximately 10% arise from pathogenic MAPT mutations and often cause severe, early-onset disease with pathology that is distinct yet partially overlapping with sporadic cases. Here, we evaluated post-mortem tissue from a patient with FTLD-tau due to MAPT S305I showing neuropathology most consistent with argyrophilic grain disease (AGD), a prevalent limbic tauopathy of aging. Structures determined by cryo-electron microscopy reveal tau filament folds that differ from those found in sporadic AGD or other tauopathies and feature a 4-layer architecture stabilized by the Ile substitution within its core. Comparative structural analysis reveals conserved motifs are shared among AGD, corticobasal degeneration, and MAPT P301T. A well-defined density stacks along a cationic cleft, indicative of a bound RNA-like polyanion or small-molecule. In vitro analysis shows the S305I mutation promotes fibrilization relative to normal tau. These results demonstrate that MAPT S305I stabilizes a distinct aggregation-prone tau fold that likely contributes to disease pathology and heterogeneity beyond its known splicing defects, and underscore potential limitations of using the most pathologically similar genetic form as a model for sporadic FTLD-tau.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Acta Neuropathologica
51 papers in training set
Top 0.1%
12.2%
2
Nature Communications
4913 papers in training set
Top 18%
10.0%
3
Alzheimer's & Dementia
143 papers in training set
Top 0.9%
7.1%
4
Molecular Neurodegeneration
49 papers in training set
Top 0.1%
7.1%
5
Acta Neuropathologica Communications
81 papers in training set
Top 0.1%
4.8%
6
Brain
154 papers in training set
Top 1%
4.3%
7
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 18%
3.9%
8
Cell Reports
1338 papers in training set
Top 15%
3.6%
50% of probability mass above
9
Neurobiology of Disease
134 papers in training set
Top 2%
3.6%
10
Journal of Biological Chemistry
641 papers in training set
Top 0.6%
3.6%
11
Advanced Science
249 papers in training set
Top 7%
2.9%
12
Molecular Therapy
71 papers in training set
Top 1%
2.3%
13
Neuron
282 papers in training set
Top 5%
2.3%
14
Neuropathology and Applied Neurobiology
14 papers in training set
Top 0.2%
2.1%
15
EMBO Molecular Medicine
85 papers in training set
Top 1%
1.9%
16
Structure
175 papers in training set
Top 1%
1.9%
17
Science Advances
1098 papers in training set
Top 18%
1.7%
18
eLife
5422 papers in training set
Top 47%
1.3%
19
Communications Biology
886 papers in training set
Top 13%
1.3%
20
Science
429 papers in training set
Top 17%
1.2%
21
Science Translational Medicine
111 papers in training set
Top 5%
0.9%
22
Scientific Reports
3102 papers in training set
Top 71%
0.9%
23
PLOS ONE
4510 papers in training set
Top 68%
0.7%
24
Aging Cell
144 papers in training set
Top 3%
0.7%
25
Molecular Psychiatry
242 papers in training set
Top 4%
0.7%
26
JCI Insight
241 papers in training set
Top 8%
0.7%
27
Cell Reports Medicine
140 papers in training set
Top 9%
0.6%
28
Nature Neuroscience
216 papers in training set
Top 7%
0.6%